ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 919,000 | $4,816,000 | 2.29% |
| RTW INVESTMENTS, LP | 6,256,840 | $32,786,000 | 2.24% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $2,515,000 | 1.08% |
| Bpifrance SA | 828,262 | $4,340,000 | 0.49% |
| WS MANAGEMENT LLLP | 888,722 | $4,657,000 | 0.28% |
| Eventide Asset Management | 1,146,580 | $6,008,000 | 0.21% |
| 683 Capital Management, LLC | 362,386 | $1,899,000 | 0.17% |
| Orbimed Advisors | 1,243,200 | $6,514,000 | 0.10% |
| Sofinnova Investments, Inc. | 159,237 | $835,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 119,673 | $627,000 | 0.07% |